About Bye Bye HIV innovation

Bye Bye HIV innovation is a formula developed from the continuous research and development work of Asian Phytoceuticals Public Company Limited led by the Operation BIM Interdisciplinary Research Team whose members were affiliated with Prince of Songkla University, Chiang Mai University and Boromarajonani College of Nursing, Chiang Mai.

It is composed of synergistic extracts from 5 types of edible plants, namely mangosteen, black sesame, soybean, guava and Centella asiatica.

It has been proven to be effective in stimulating Th1 and Th17 white blood cells 2 times and 5 times, respectively, when using only 4 capsules (2g) per day continuously for 15 days.  The increase in Th1 and Th17 cells boosts the potency of Killer T-cells to eliminate HIV-infected cells with high efficiency without adversely affecting normal cells in the body.

Therefore, this is the way to kill the HIV hidden in white blood cells without any side effects.

The research team that has developed Bye Bye HIV Innovation consists of experts who have developed a formula to rebuild telomeres and have applied their knowledge base to develop the Bye Bye HIV formula.

The National Innovation Agency of Thailand (NIA) on 4 September 2015 recognized the achievements of Bye Bye HIV as Thailand's National Innovation in improving the lives of people globally.

The Operation BIM Research Team

Dr. Pichaet Wiriyachitra

CEO
Asian Phytoceuticals Public Company Limited

Dr. Ampai Panthong

Department of Pharmacology, Faculty of Medicine
Chiang Mai University

Dr. Kannikar Ruenchan

Boromarajonani College of Nursing, Chiang Mai
AIDS expert

Dr. Souwalak Phongpaichit

Department of Microbiology, Faculty of Science
Prince of Songkla University

Dr. Wilawan Mahabudsarakam

Department of Chemistry, Faculty of Science
Prince of Songkla University

Ms. Sirithip Wiriyachitra

Immunologist
Asian Phytoceuticals Public Company Limited

Asian Phytoceuticals Public Company Limited  (“The Company” or “APCO”) was founded on 2 June 1988 under the name Natural Cosmetic Research Co., Ltd. to operate the business of manufacturing and distributing beauty & cosmetic products and dietary supplements developed from natural plant and botanical extracts. In 2005 the Company registered its conversion to a public company limited and at the same time changed its name to Asian Phytoceuticals Public Company Limited.  On 4 November 2011 the Company was listed on the Market for Alternative Investment (MAI) under the stock symbol “APCO”.  On 14 May 2018 it was moved to be traded as listed securities on the Stock Exchange of Thailand (SET).

11 individuals getting off antivirals & Bye Bye HIV with APCO Immunotherapy

Miss Praew: Bye Bye HIV with Thailand's Innovation

Mr. James: Bye Bye HIV with Thailand's Innovation

Mr. Ball: Bye Bye HIV with Thailand's Innovation

Miss Thip: Bye Bye HIV with Thailand's Innovation

Bye Bye HIV for people who have never used antivirals with Thailand's Innovation

HIV Successful Treatment with APCO Immunotherapy How It Works